Screener
Amphastar Pharmaceuticals AMPH Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Income tax provision | 8,196 | 8,305 | 11,828 | 13,882 |
| Net income | $30,348 | $31,030 | $36,768 | $56,315 |
| Net income per share: | ||||
| Basic | $0.69 | $0.66 | $0.83 | $1.19 |
| Diluted | $0.67 | $0.64 | $0.81 | $1.15 |
| Weighted-average shares used to compute net income per share: | ||||
| Basic | 43,644 | 46,949 | 44,483 | 47,295 |
| Diluted | 44,225 | 48,128 | 45,341 | 49,009 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's shares (diluted)?
- Amphastar Pharmaceuticals (AMPH) reported shares (diluted) of 44.2M in Q2 2026.
- How has Amphastar Pharmaceuticals's shares (diluted) changed year-over-year?
- Amphastar Pharmaceuticals's shares (diluted) decreased by 8.1% year-over-year, from 48.1M to 44.2M.
- What is the long-term trend for Amphastar Pharmaceuticals's shares (diluted)?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's shares (diluted) has grown at a -0.6% compound annual growth rate (CAGR), from 198.9M to 193.9M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Amphastar Pharmaceuticals's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude